Family Medicine · Astoria, NY
NPI
1104939891
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
2138 31st St
Astoria, NY, 11105
Phone (718) 626-2700
Groups this clinician bills Medicare through
Medicare paid, 2024
$35K
604 services
Medicare patients, 2024
98
Average age 71
Drug cost, 2024
$5.4M
19,558 prescriptions
Company payments, 2025
$1,070
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amr Nayel was code 99214 (office e&m - established), 171 times for 85 patients. In total Amr Nayel billed 604 services in 40 codes, and Medicare paid $35K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 171 | 85 | $95.32 | $16K |
| 36415 Venipuncture Blood Collection | Office | 119 | 77 | $8.65 | $1,029 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 52 | 52 | $144.59 | $7,519 |
| 81002 Clinical Chemistry | Office | 51 | 41 | $3.41 | $174 |
| 99213 Office E&M - Established | Office | 46 | 37 | $69.99 | $3,220 |
| 99212 Office E&M - Established | Office | 27 | 20 | $41.64 | $1,124 |
| 93000 Electrocardiogram | Office | 26 | 23 | $11.43 | $297 |
| 90662 Vaccine Product | Office | 16 | 16 | $79.35 | $1,270 |
By year: 2022 $1,515 for 31 services; 2023 $22K for 309 services; 2024 $35K for 604 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 119 | 77 | $8.65 | $1,029 |
| 81002 Clinical Chemistry | 51 | 41 | $3.41 | $174 |
Medicare prescription drug claims, 2024
In 2024, the drug Amr Nayel prescribed most often to Medicare patients was Atorvastatin Calcium, with 739 prescriptions and refills. In total Amr Nayel wrote 19,558 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 739 | 1,876 | 196 | $7,631 |
| Tamsulosin Hcl Generic | 593 | 1,415 | 148 | $8,298 |
| Janumet Sitagliptin Phos/Metformin Hcl | 482 | 806 | 91 | $425K |
| Gabapentin Generic | 432 | 674 | 104 | $4,015 |
| Metoprolol Succinate Generic | 430 | 1,027 | 109 | $6,965 |
| Metformin Hcl Generic | 412 | 934 | 115 | $2,725 |
| Ozempic Semaglutide | 412 | 516 | 73 | $459K |
| Losartan Potassium Generic | 386 | 1,009 | 110 | $3,444 |
| Amlodipine Besylate Generic | 382 | 933 | 111 | $2,380 |
| Rosuvastatin Calcium Generic | 372 | 1,011 | 117 | $5,385 |
| Diclofenac Sodium Generic | 355 | 524 | 117 | $256K |
| Famotidine Generic | 331 | 674 | 86 | $32K |
| Omeprazole Generic | 329 | 786 | 100 | $4,423 |
| Pantoprazole Sodium Generic | 320 | 676 | 79 | $2,618 |
| Vascepa Icosapent Ethyl | 297 | 409 | 57 | $129K |
Brand drugs: 4,886 claims; generic drugs: 13,913 claims; opioid claims: 184.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amr Nayel $1,070 ($1,070 in general payments such as food, travel and fees) from 17 companies. The largest payer was Mannkind Corporation with $169.
| Company | Payments | Amount |
|---|---|---|
| Mannkind Corporation MNKD | 6 | $169 |
| Novo Nordisk Inc NVO | 7 | $160 |
| Abbvie Inc. ABBV | 3 | $154 |
| Biotronik Inc. | 1 | $154 |
| Amgen Inc. AMGN | 3 | $75.66 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $54.99 |
| Astellas Pharma US Inc 4503.T | 2 | $47.34 |
| Kowa Pharmaceuticals America, Inc. | 2 | $46.94 |
| Exact Sciences Corporation EXAS | 1 | $26.53 |
| AstraZeneca Pharmaceuticals LP AZN | 1 | $25.02 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.